Vimarsana
Biggest News Aggregation in the World

Page 2 - Earlipoint Evaluation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Earlipoint Evaluation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Earlipoint Evaluation Today - Breaking & Trending Today

Marcus Autism Center EarliPoint Evaluation for early autism - Vimarsana News

Marcus Autism Center EarliPoint Evaluation for early autism

Called the EarliPoint Evaluation, the tool has been authorized by the FDA for use with children between the ages of 16 and 30 months.

Eye-Tracking Device Shows Promise in Speeding up Autism Diagnosis - Vimarsana News

Eye-Tracking Device Shows Promise in Speeding up Autism Diagnosis

An innovative FDA-approved technology that measures children's eye movements while watching social interaction movies may speed up autism spectrum disorder diagnosis.

Is an eye-tracking device a simpler way to detect autism? - Vimarsana News

Is an eye-tracking device a simpler way to detect autism?

Autism is typically diagnosed in children when they are 4 or 5 years old, but a new tool could make earlier detection and intervention possible.

Source: ksl.com
Researchers unveil eye-tracking device to speed up autism diagnosis in kids - Vimarsana News

Researchers unveil eye-tracking device to speed up autism diagnosis in kids

A revolutionary tool that monitors children's eye movements while they watch a video of a social interaction between two children could hasten the diagnosis of autism spectrum condition, according...

New Eye-Tracking Tool Can Improve Early Autism Diagnosis, Studies Show - Vimarsana News

New Eye-Tracking Tool Can Improve Early Autism Diagnosis, Studies Show

Two recent studies suggest that a newly developed eye-tracking tool may revolutionize the diagnosis of autism in young children. Currently, families often face long wait times for a diagnosis, and even then, the diagnosis may not be definitive. However, this tool, called EarliPoint Evaluation, has been cleared by the US Food and Drug Administration to assist clinicians in diagnosing and assessing autism.